Fewer patients with diabetes in Asia were treated with insulin and/or biguanides, and roughly twice as many patients in Asia were treated with dipeptidyl peptidase-4 inhibitors compared with patients in Europe or Latin America. Here, DPP4 is linked to diabetes mellitus.